NASDAQ:REGN | Cash Flow Statement | REGENERON PHARMACEUTICALS, INC.

Complete source-backed cash-flow history.

Available history
2008-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30$1.3B
2026-03-31$727.2M$123.2M$1.08B-$428.9M$794.3M$97.8M-$802.2M
2025-12-31$844.6M$145M$1.17B$220.3M$671.7M$92.7M-$780.1M
2025-09-30$1.46B
2025-06-30$1.39B
2025-03-31$808.7M$126.9M$1.05B$647.5M$1.04B$93.8M-$1.09B
2024-12-31$917.7M$126.4M$1.26B$350.6M$973M$0.00-$1.14B
2024-09-30$1.34B
2024-06-30$1.43B
2024-03-31$722M$114.1M$1.51B-$1.69B$291.3M$0.00$47.1M
2023-12-31$1.16B$113M$1.09B-$66.2M$289M-$446.1M
2023-09-30$1.01B
2023-06-30$968.4M
2023-03-31$817.8M$99.5M$1.37B-$235.7M$710.7M-$322.5M
2022-12-31$1.2B$100.1M$1.72B-$1.86B$431.1M-$247.6M
2022-09-30$1.32B
2022-06-30$852.1M
2022-03-31$973.5M$74.3M$2.1B-$1.71B$358.1M$64.7M
2021-12-31$2.23B$74.5M$2.37B-$2.01B$866.9M-$906.6M
2021-09-30$1.63B
2021-06-30$3.1B
2021-03-31$1.12B$67.4M$668.5M-$1.06B$306.9M-$366.4M
2020-12-31$1.15B$61.7M$1.23B-$305M$381.1M-$305.3M
2020-09-30$842.1M
2020-06-30$897.3M
2020-03-31$624.6M$56.1M$698M-$443.2M$320.7M$335.6M
2019-12-31$792M$54.3M$787.4M-$208.7M$246.5M-$345.7M
2019-09-30$669.6M
2019-06-30$193.1M
2019-03-31$461.1M$51M$897M-$776.1M$10M$119.9M
2018-12-31$820.4M$42.8M$728.8M-$265.9M$0.00-$83M
2018-09-30$594.7M
2018-06-30$551.4M
2018-03-31$477.9M$36.4M$618.8M-$425.4M$0.00$13.4M
2017-12-31$173.51M$34.54M$566.94M-$335.76M$0.00-$210.54M
2017-09-30$388.32M
2017-06-30$387.74M
2017-03-31$248.93M$38.12M$355.9M-$140.14M$60.81M
2016-12-31$253.09M$28.86M$390.38M-$271.25M-$491.79M
2016-09-30$264.8M
2016-06-30$196.22M
2016-03-31$181.39M$22.98M$44.99M-$43.69M-$206.19M
2015-12-31$154.99M$22.91M$281.82M-$123.3M-$4.01M
2015-09-30$210.4M
2015-06-30$194.64M
2015-03-31$76.02M$16.03M-$101.73M-$129.48M$90.4M
2014-12-31$90.1M$14.14M$198.18M$56.65M-$252.66M
2014-09-30$83.38M
2014-06-30$96.35M
2014-03-31$68.31M$11.53M$53.53M-$236.23M$108.95M
2013-12-31$86.18M$11.29M$281.73M-$109.95M$100.62M
2013-09-30$141.31M
2013-06-30$87.38M
2013-03-31$98.87M$9.41M$86.25M-$147.69M$11.52M
2012-12-31$470.41M$9.78M$93.19M$91.1M-$73.01M
2012-09-30$191.47M
2012-06-30$76.74M
2012-03-31$11.65M$8.42M-$87.04M$15.77M-$17.75M
2011-12-31-$53.44M$7.93M-$50.32M-$33.91M$361.44M
2011-09-30-$62.37M
2011-06-30-$62.51M
2011-03-31-$43.45M$6.98M-$10.58M$20.35M$13.04M
2010-12-31-$14.6M$6.09M-$40.85M-$354.62M$182.76M
2010-09-30-$33.88M
2010-06-30-$25.47M
2010-03-31-$30.52M$4.18M-$9.58M-$136.4M$56.22M
2009-12-31-$36.49M$4.89M-$44.11M-$21.46M$22.33M
2009-09-30-$1.02M
2009-06-30-$14.94M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31$4.5B$543.7M$4.98B-$629.1M$3.44B$370.3M-$3.72B
2024-12-31$4.41B$482.9M$4.42B-$2.47B$2.6B$0.00-$2.2B
2023-12-31$3.95B$421M$4.59B-$3.19B$2.24B$0.00-$1.79B
2022-12-31$4.34B$341.4M$5.01B-$3.78B$2.08B-$1.01B
2021-12-31$8.08B$286.2M$7.08B-$5.38B$1.65B-$1.01B
2020-12-31$3.51B$235.9M$2.62B-$70.6M$5.85B-$1.97B
2019-12-31$2.12B$210.3M$2.43B-$2.03B$275.9M-$252.1M
2018-12-31$2.44B$148.2M$2.2B-$1.46B$4.4M-$77.1M
2017-12-31$1.2B$145.5M$1.31B-$1.01B$0.00-$24.4M
2016-12-31$895.5M$104.7M$1.49B-$1.05B$0.00-$700.5M
2015-12-31$636.06M$74.91M$1.33B-$907.6M-$262.8M
2014-12-31$338.13M$52.69M$752.44M-$420.78M-$218.55M
2013-12-31$413.74M$41.2M$588.6M-$355.46M$72.19M
2012-12-31$750.27M$36.94M-$74.62M-$81.07M-$97.65M
2011-12-31-$221.76M$31.08M-$141.68M$128.47M$384.25M
2010-12-31-$104.47M$19.69M$99.22M-$437.03M$243.31M
2009-12-31-$67.83M$14.2M-$69.94M-$2.15M$31.36M
2008-12-31-$79.13M$11.29M-$89.09M$30.82M-$192.86M